Jim Simons Omeros Corp Transaction History

Renaissance Technologies LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$2.81 - $5.69 $176,468 - $357,332	62,800 New	62,800 $183,000
Q2 2022 Aug 12, 2022	BUY	$1.92 - $6.28 $473,856 - $1.55 Million	246,800 Added 84.06%	540,400 $1.49 Million
Q1 2022 May 13, 2022	BUY	$5.07 - $7.2 $1.09 Million - $1.54 Million	214,200 Added 269.77%	293,600 $1.77 Million
Q4 2021 Feb 11, 2022	BUY	$5.67 - $8.54 $450,198 - $678,075	79,400 New	79,400 $511,000
Q3 2021 Nov 12, 2021	SELL	$13.4 - $16.3 $2.64 Million - $3.21 Million	-197,035 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$14.81 - $19.13 $2.92 Million - $3.77 Million	197,035 New	197,035 $2.92 Million
Q1 2019 May 14, 2019	SELL	$11.65 - $17.72 $783,287 - $1.19 Million	-67,235 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$10.72 - $16.73 $720,759 - $1.12 Million	67,235 New	67,235 $749,000

120

25.6M

228K

630K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $747M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.